Literature DB >> 24725491

Optimization of prostate biopsy: review of technique and complications.

Marc A Bjurlin1, James S Wysock1, Samir S Taneja2.   

Abstract

A 12-core systematic biopsy that incorporates apical and far-lateral cores in the template distribution allows maximal cancer detection and avoidance of a repeat biopsy while minimizing the detection of insignificant prostate cancers. Magnetic resonance imaging-guided prostate biopsy has an evolving role in both initial and repeat prostate biopsy strategies, potentially improving sampling efficiency, increasing the detection of clinically significant cancers, and reducing the detection of insignificant cancers. Hematuria, hematospermia, and rectal bleeding are common complications of prostate needle biopsy, but are generally self-limiting and well tolerated. All men should receive antimicrobial prophylaxis before biopsy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy core number; Magnetic resonance imaging; Prostate needle biopsy; Quinolone-reistant infection

Mesh：

Year:  2014        PMID： 24725491      PMCID： PMC4151475          DOI： 10.1016/j.ucl.2014.01.011

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  127 in total

1.  High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.

Authors:  Nicola J Mabjeesh; Ghalib Lidawi; Juza Chen; Larissa German; Haim Matzkin
Journal:  BJU Int       Date:  2012-03-06       Impact factor: 5.588

2.  Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

Authors:  Samir S Taneja; Ronald Morton; Gary Barnette; Paul Sieber; Michael L Hancock; Mitchell Steiner
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

3.  Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.

Authors:  Hebert Alberto Vargas; Oguz Akin; Asim Afaq; Debra Goldman; Junting Zheng; Chaya S Moskowitz; Amita Shukla-Dave; James Eastham; Peter Scardino; Hedvig Hricak
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

4.  Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy.

Authors:  Brian T Helfand; Alexander P Glaser; Kalen Rimar; Sherwin Zargaroff; Jason Hedges; Barry B McGuire; William J Catalona; Kevin T McVary
Journal:  BJU Int       Date:  2012-05-28       Impact factor: 5.588

5.  Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.

Authors:  Stacy Loeb; H Ballentine Carter; Sonja I Berndt; Winnie Ricker; Edward M Schaeffer
Journal:  J Urol       Date:  2012-10-09       Impact factor: 7.450

6.  Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance.

Authors:  Jeffrey K Mullins; David Bonekamp; Patricia Landis; Hosne Begum; Alan W Partin; Jonathan I Epstein; H Ballentine Carter; Katarzyna J Macura
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

7.  Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes.

Authors:  R Chowdhury; A Abbas; S Idriz; A Hoy; E E Rutherford; J M Smart
Journal:  Clin Radiol       Date:  2012-09-07       Impact factor: 2.350

Review 8.  MRI-ultrasound fusion for guidance of targeted prostate biopsy.

Authors:  Leonard Marks; Shelena Young; Shyam Natarajan
Journal:  Curr Opin Urol       Date:  2013-01       Impact factor: 2.309

9.  Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?

Authors:  Alex Carignan; Jean-François Roussy; Véronique Lapointe; Louis Valiquette; Robert Sabbagh; Jacques Pépin
Journal:  Eur Urol       Date:  2012-05-03       Impact factor: 20.096

10.  Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.

Authors:  Adam W Nelson; Rebecca C Harvey; Richard A Parker; Christof Kastner; Andrew Doble; Vincent J Gnanapragasam
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
View more
  30 in total

1.  Comparison of two different doses of lidocaine on the pain sensation during transrectal ultrasound-guided prostate biopsy.

Authors:  Ferhat Ateş; Furkan Dursun; Ercan Malkoç; Ömer Yılmaz; Hasan Soydan; Hüseyin Şen; Şeref Başal; Fatih Zekey; Kenan Karademir
Journal:  Turk J Urol       Date:  2016-09

Review 2.  Standards for prostate biopsy.

Authors:  Marc A Bjurlin; Samir S Taneja
Journal:  Curr Opin Urol       Date:  2014-03       Impact factor: 2.309

Review 3.  HistoScanningTM to Detect and Characterize Prostate Cancer-a Review of Existing Literature.

Authors:  James S Wysock; Alex Xu; Clement Orczyk; Samir S Taneja
Journal:  Curr Urol Rep       Date:  2017-10-24       Impact factor: 3.092

4.  The effect of ultrasound-guided compression immediately after transrectal ultrasound-guided prostate biopsy on postbiopsy bleeding: a randomized controlled pilot study.

Authors:  Bong Hee Park; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Chang Hee Han
Journal:  Int Urol Nephrol       Date:  2017-05-04       Impact factor: 2.370

5.  Transrectal ultrasound guided prostate biopsy performed by supervised junior and senior residents is safe and does not result in inferior outcomes.

Authors:  Jesse F Wang; Margaret A Knoedler; Kimberly A Maciolek; Natasza M Posielski; Vania Lopez; Wade A Bushman; Sara L Best; Dan R Gralnek; Kyle A Richards
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

6.  The effect of heated lidocaine gel on pain reduction during transrectal ultrasound-guided prostate biopsy: a randomized-controlled study.

Authors:  Joon Se Jung; Hee Nam Moon; Jung Im Kim; Sang Rak Bae; Chang Hee Han; Bong Hee Park
Journal:  Int Urol Nephrol       Date:  2021-09-30       Impact factor: 2.370

7.  A novel method for pain control: infiltration free local anesthesia technique (INFLATE) for transrectal prostatic biopsy using transcutaneous electrical nerve stimulation (TENS).

Authors:  Mustafa Suat Bolat; Onder Cinar; Ramazan Asci; Recep Buyukalpelli
Journal:  Int Urol Nephrol       Date:  2019-09-06       Impact factor: 2.370

8.  A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.

Authors:  M J Donovan; M Noerholm; S Bentink; S Belzer; J Skog; V O'Neill; J S Cochran; G A Brown
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-09-08       Impact factor: 5.554

Review 9.  Optimizing safety and accuracy of prostate biopsy.

Authors:  Tonye A Jones; Jan Phillip Radtke; Boris Hadaschik; Leonard S Marks
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

10.  Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.

Authors:  Matthew R Cooperberg; Yingye Zheng; Anna V Faino; Lisa F Newcomb; Kehao Zhu; Janet E Cowan; James D Brooks; Atreya Dash; Martin E Gleave; Frances Martin; Todd M Morgan; Peter S Nelson; Ian M Thompson; Andrew A Wagner; Peter R Carroll; Daniel W Lin
Journal:  JAMA Oncol       Date:  2020-10-08       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.